Approval · Notice of Compliance 12807 · 2011
MODULON: Notice of Compliance 12807
Issued November 20, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12807
- Date
- November 20, 2011
- Company
- Aptalis Pharma Canada UlcMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer Name Change
- Therapeutic class
- Lower Gastrointestinal Tract Motility Regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MODULON | 00803499 | Cancelled Post Market |
Medicinal ingredients
- TRIMEBUTINE MALEATE 200 MG per TAB